Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Avid Bioservices Inc | CDMO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 7.32 | 03:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.32 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 4.0705 - 18.86 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 7.32 | USD |
Avid Bioservices Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 462.91M | 63.24M | - | 149.27M | 560k | 0.01 | 822.47 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Avid Bioservices News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDMO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.49 | 7.40 | 6.23 | 6.88 | 1,061,912 | 0.83 | 12.79% |
| 1 Month | 6.62 | 7.59 | 6.175 | 6.74 | 996,082 | 0.70 | 10.57% |
| 3 Months | 6.42 | 8.83 | 5.90 | 6.78 | 1,374,418 | 0.90 | 14.02% |
| 6 Months | 6.63 | 8.83 | 4.0705 | 6.28 | 1,398,945 | 0.69 | 10.41% |
| 1 Year | 18.55 | 18.86 | 4.0705 | 8.11 | 989,410 | -11.23 | -60.54% |
| 3 Years | 21.33 | 34.51 | 4.0705 | 15.19 | 760,959 | -14.01 | -65.68% |
| 5 Years | 4.59 | 34.51 | 3.02 | 13.65 | 623,758 | 2.73 | 59.48% |
Avid Bioservices Description
| Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. |
